Shandong Yongchuntang Group Co., Ltd entered into an Acer Truncatum Industrial Project acquisition agreement to acquire 3% stake in Shandong Spring Pharmaceutical Co., Ltd. from China YCT International Group, Inc (OTCPK:CYIG) on March 18, 2017. Under the transaction, Shandong Yongchuntang Group Co., Ltd. acquired 3% shares and in consideration China YCT International Group, Inc received Acer Truncatum Industrial Project which was owned by Shandong Yongchuntang Group. In addition to this, China YCT International Group agreed to add a person designated by Shandong Yongchuntang Group to its Board of Directors.